Literature DB >> 8805280

Post-natal lethality and neurological and gastrointestinal defects in mice with targeted disruption of the A-Raf protein kinase gene.

C A Pritchard1, L Bolin, R Slattery, R Murray, M McMahon.   

Abstract

The Ras/Raf/MEK/MAP kinase cascade transmits signals from activated cell-surface receptors to transcription factors in the nucleus and is an essential component of metazoan intracellular signaling pathways (see, for example, [1-6]). In the mouse, the Raf protein kinase family is comprised of three homologous genes, Raf-1, A-Raf and B-Raf [5] which are ubiquitously expressed in the developing embryo [7]. We have introduced into the mouse germ line a loss-of-function mutation in the X-chromosomal A-Raf gene, by homologous recombination in embryonic stem cells. On a predominantly C57 Bl/6 genetic background, A-Raf-deficient mice displayed neurological and intestinal abnormalities and died between 7 and 21 days post-partum. When the mutated allele was maintained on a predominantly 129/OLA background, by contrast, A-Raf-deficient animals survived to adulthood, did not display obvious intestinal abnormalities, were fertile, but did have a subset of the neurological defects.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8805280     DOI: 10.1016/s0960-9822(02)00548-1

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  49 in total

1.  B-Raf inhibits programmed cell death downstream of cytochrome c release from mitochondria by activating the MEK/Erk pathway.

Authors:  P Erhardt; E J Schremser; G M Cooper
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

2.  c-Raf regulates cell survival and retinal ganglion cell morphogenesis during neurogenesis.

Authors:  B Pimentel; C Sanz; I Varela-Nieto; U R Rapp; F De Pablo; E J de La Rosa
Journal:  J Neurosci       Date:  2000-05-01       Impact factor: 6.167

Review 3.  Opioid receptor trafficking and signaling: what happens after opioid receptor activation?

Authors:  Jia-Ming Bian; Ning Wu; Rui-Bin Su; Jin Li
Journal:  Cell Mol Neurobiol       Date:  2011-09-25       Impact factor: 5.046

4.  Noonan syndrome: clinical aspects and molecular pathogenesis.

Authors:  M Tartaglia; G Zampino; B D Gelb
Journal:  Mol Syndromol       Date:  2010-01-15

Review 5.  Growth factor signaling pathways as targets for prevention of epithelial carcinogenesis.

Authors:  Okkyung Rho; Dae Joon Kim; Karou Kiguchi; John Digiovanni
Journal:  Mol Carcinog       Date:  2010-07-20       Impact factor: 4.784

6.  Cortical migration defects in mice expressing A-RAF from the B-RAF locus.

Authors:  Guadalupe Camarero; Oleg Yu Tyrsin; Chaomei Xiang; Verena Pfeiffer; Sandra Pleiser; Stefan Wiese; Rudolf Götz; Ulf R Rapp
Journal:  Mol Cell Biol       Date:  2006-10       Impact factor: 4.272

7.  Borna disease virus-induced neurological disorder in mice: infection of neonates results in immunopathology.

Authors:  W Hallensleben; M Schwemmle; J Hausmann; L Stitz; B Volk; A Pagenstecher; P Staeheli
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

Review 8.  Phospholipase D: enzymology, functionality, and chemical modulation.

Authors:  Paige E Selvy; Robert R Lavieri; Craig W Lindsley; H Alex Brown
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

9.  Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1.

Authors:  D Woods; D Parry; H Cherwinski; E Bosch; E Lees; M McMahon
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

Review 10.  Regulation of RAF protein kinases in ERK signalling.

Authors:  Hugo Lavoie; Marc Therrien
Journal:  Nat Rev Mol Cell Biol       Date:  2015-05       Impact factor: 94.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.